0	1	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 13), 'text':'Differential Role of Human Choline Kinase alpha and beta Enzymes in Lipid Metabolism :'}, {'start':(0, 14), 'end':(0, 19), 'text':'Implications in Cancer Onset and Treatment'}]}
112	173	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Discussion'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 14), 'text':'The family of human choline and ethanolamine kinases comprises two genes , CHKA and CHKB'}, {'start':(1, 15), 'end':(1, 38), 'text':'that codify for three enzymes , ChoKalpha1 ( 52 kDa ) , ChoKalpha2 ( 50 kDa ) and ChoKbeta1 ( 45 kDa ) .'}]}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 18), 'text':'ChoKalpha1 and ChoKalpha2 are almost identical , except for a stretch of 18 extra amino acids in ChoKalpha1 ,'}, {'start':(2, 19), 'end':(2, 31), 'text':'as they result from differential splicing from the same gene , CHKA .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(3, 0), 'end':(3, 26), 'text':'While the implication of ChoKalpha1 in the regulation of cell growth and cancer has been extensively demonstrated , , , , , , , preliminary evidence suggest'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 27), 'end':(3, 34), 'text':'that ChoKbeta may not be involved in carcinogenesis'}, {'start':(3, 35), 'end':(3, 53), 'text':'since it is not overexpressed in breast cancer cell lines nor in the TRAMP mouse prostate cancer model .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(4, 0), 'end':(4, 7), 'text':'A distinct human gene family has been described'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 8), 'end':(4, 13), 'text':'that codifies for EtnK activity ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(4, 14), 'end':(4, 14), 'text':'suggesting'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 15), 'end':(4, 20), 'text':'that EtnK1 is the main enzyme'}, {'start':(4, 21), 'end':(4, 25), 'text':'involved in PE homeostasis .'}]}]}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 11), 'text':'The ChoK and EtnK domain confers to ChoKalpha and ChoKbeta the ability'}, {'start':(5, 12), 'end':(5, 24), 'text':'to function as both ChoK and EtnK activity under cell-free conditions , -,'}]}, {'label':'condition', 'direction':'LeftToRight', 'children':[{'start':(5, 25), 'end':(5, 29), 'text':'but it is still unknown'}, {'start':(5, 30), 'end':(5, 54), 'text':'if these previously characterized enzymes showed any selectivity to each branch of the Kennedy pathway in the de novo synthesis of PC or PE .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 23), 'text':'It has been recently described the different specificity towards Cho and Etn of the two isoforms of Cho and EtnK of Tripanosoma brucei .'}, {'start':(7, 0), 'end':(7, 20), 'text':'Whereas TbCho and Etn1 displays only EtnK activity , TbCho and Etn2 displays both ChoK and EtnK activities in vitro .'}]}, {'label':'explanation', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 6), 'text':'These results are in keeping with those'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 7), 'end':(8, 10), 'text':'described for murine EtnK1'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 11), 'end':(8, 16), 'text':'that is Etn specific and EtnK2'}, {'start':(8, 17), 'end':(8, 26), 'text':'that displays a dual ChoK and EtnK function , .'}]}]}]}, {'label':'contrast', 'direction':'None', 'children':[{'start':(9, 0), 'end':(9, 22), 'text':'On the other hand , whereas murine Pcyt1alpha and Pcyt1beta are involved in PC biosynthesis , Pcyt2 is focused to PE only .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 7), 'text':'However , it is not yet fully understood'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 8), 'end':(10, 20), 'text':'which ChoK isoform , if any , contributes in vivo in each pathway'}, {'start':(10, 21), 'end':(10, 34), 'text':'to maintain the normal homeostasis of both PC and PE in biological membranes .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 1), 'text':'The results'}, {'start':(11, 2), 'end':(11, 4), 'text':'shown here confirm'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 5), 'end':(11, 10), 'text':'that both enzymes have the ability'}, {'start':(11, 11), 'end':(11, 19), 'text':'to phosphorylate choline and ethanolamine under cell-free conditions ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 20), 'end':(11, 23), 'text':'either as recombinant proteins'}, {'start':(11, 24), 'end':(11, 36), 'text':'produced in E. coli , or in cell extracts from mammalian cells .'}]}]}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(12, 0), 'end':(12, 3), 'text':'However , we found'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 4), 'end':(12, 12), 'text':'that under whole cell conditions ChoKalpha1 has the ability'}, {'start':(12, 13), 'end':(12, 20), 'text':'to function as both ChoK and EtnK ,'}]}]}, {'start':(12, 21), 'end':(12, 29), 'text':'but ChoKbeta only affects the production of PEtn .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 32), 'text':'These findings of different roles for alpha and beta isoforms are in keeping with the information from the recently generated Knock Out ( KO ) mice for ChoKalpha and ChoKbeta genes , .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(14, 0), 'end':(14, 11), 'text':'Thus , ChoKbeta KO mice ( rmd mice ) are viable ,'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(14, 12), 'end':(14, 18), 'text':'but develop a rostrocaudal muscular dystrophy ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 19), 'end':(14, 28), 'text':'while normal PC lipid levels are found in most tissues'}, {'start':(14, 29), 'end':(14, 35), 'text':'analyzed except in hindlimb skeletal muscle .'}]}]}]}, {'start':(15, 0), 'end':(15, 13), 'text':'Therefore , ChoKalpha is sufficient to maintain normal PC levels in most tissues .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(16, 0), 'end':(16, 11), 'text':'By contrast , the lack of ChoKalpha results in embryonic lethality ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 12), 'end':(16, 32), 'text':'and ChoKalpha + /- heterozygous mice display an accumulation of Cho and a reduction in PCho in liver and testis ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(16, 33), 'end':(16, 33), 'text':'suggesting'}, {'start':(16, 34), 'end':(16, 45), 'text':'that there is no ChoKbeta compensation for PC biosynthesis in vivo .'}]}]}]}, {'start':(17, 0), 'end':(17, 13), 'text':'These results suggest different roles in vivo for both ChoKalpha and ChoKbeta isoforms .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 6), 'text':'Furthermore , the attenuated levels in PE'}, {'start':(18, 7), 'end':(18, 32), 'text':'found in ChoKalpha + /- heterozygous mice suggest the involvement of ChoKalpha not only in the biosynthesis of PC but also in the PE pathway .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 0), 'end':(19, 6), 'text':'This is also consistent with the fact'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(19, 7), 'end':(19, 12), 'text':'that in ChoKbeta KO mice ,'}, {'start':(19, 13), 'end':(19, 17), 'text':'PE levels are unaffected ,'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(19, 18), 'end':(19, 18), 'text':'indicating'}, {'label':'joint', 'direction':'None', 'children':[{'start':(19, 19), 'end':(19, 27), 'text':'that PE homeostasis is fully maintained with the EtnK1'}, {'start':(19, 28), 'end':(19, 32), 'text':'and ChoKalpha proteins intact .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(20, 0), 'end':(20, 19), 'text':'The group of Ishidate has provided valuable information about the in vitro activity of ChoK from different mouse tissues ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(20, 20), 'end':(20, 23), 'text':'and they have postulated'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 24), 'end':(20, 38), 'text':'that the most active form for choline kinase activity is the alpha and alpha homodimer'}, {'start':(20, 39), 'end':(20, 45), 'text':'followed by alpha and beta heterodimers ,'}]}, {'start':(20, 46), 'end':(20, 56), 'text':'being the beta and beta homodimer the least active form .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 13), 'text':'The in vivo results shown here are partially in keeping with this hypothesis .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(22, 0), 'end':(22, 10), 'text':'The in vivo activity of ChoKbeta is focused in PE biosynthesis'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 11), 'end':(22, 24), 'text':'and displays higher Km for choline than ChoKalpha , this could be the reason'}, {'start':(22, 25), 'end':(22, 34), 'text':'why beta and beta dimers show low ChoK activity .'}]}]}, {'start':(23, 0), 'end':(23, 18), 'text':'When ChoKbeta was overexpressed we observed an increase in the intracellular levels of PEtn but not of PCho .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 20), 'text':'However no differences were found between both isoforms for the generation of PEtn , since both display similar EtnK activity .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 10), 'text':'PCho has been proposed to promote mitogenesis in mammalian cells .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(26, 0), 'end':(26, 17), 'text':'In keeping with this , magnetic resonance spectroscopy techniques have revealed higher levels of phosphomonoesthers in tumoral samples'}, {'label':'joint', 'direction':'None', 'children':[{'start':(26, 18), 'end':(26, 24), 'text':'when compared to their normal counterparts -.'}, {'label':'joint', 'direction':'None', 'children':[{'start':(27, 0), 'end':(27, 7), 'text':'Moreover , overexpression of ChoKalpha1 is oncogenic ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 8), 'end':(27, 18), 'text':'and enhanced ChoKalpha activity is a frequent feature in tumoral samples'}, {'start':(27, 19), 'end':(27, 24), 'text':'compared to normal tissues , .'}]}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(28, 0), 'end':(28, 6), 'text':'Taken together all these results strongly indicate'}, {'start':(28, 7), 'end':(28, 19), 'text':'that ChoKalpha1 activity and PCho levels have a strong implication in cancer .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(29, 0), 'end':(29, 15), 'text':'Furthermore , overexpression of ChoKalpha1 results in an increase in EtnK activity and PEtn levels .'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(30, 0), 'end':(30, 13), 'text':'However the latter effect by itself is not sufficient to induce cell transformation ,'}, {'start':(30, 14), 'end':(30, 32), 'text':'since overexpression of ChoKbeta does not induce enhanced colony formation in soft-agar or tumor growth in nude mice .'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(31, 0), 'end':(31, 6), 'text':'These results are consistent with the hypothesis'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 7), 'end':(31, 21), 'text':'that it is the production of PCho what is linked to cell proliferation and transformation'}, {'start':(31, 22), 'end':(31, 25), 'text':'mediated by ChoK ,'}]}, {'start':(31, 26), 'end':(31, 41), 'text':'and that the production of PEtn may not be sufficient or relevant in this process .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(32, 0), 'end':(32, 3), 'text':'The above results suggest'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(32, 4), 'end':(32, 18), 'text':'that the two ChoK isoforms investigated , besides their similarity in their primary sequences ,'}, {'start':(32, 19), 'end':(32, 25), 'text':'are implicated in different metabolic pathways .'}]}]}, {'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(33, 0), 'end':(33, 10), 'text':'Thus while ChoKalpha1 impinges into both PC and PE synthesis ,'}, {'start':(33, 11), 'end':(33, 16), 'text':'ChoKbeta affects only PE synthesis .'}]}]}, {'start':(34, 0), 'end':(34, 13), 'text':'Furthermore , the transformation capacity seems to be exclusive to the ChoKalpha isoform .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(35, 0), 'end':(35, 1), 'text':'However ,'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(35, 2), 'end':(35, 13), 'text':'since in the human HEK293T , Sk-Br-3 and H1299 cell lines ,'}, {'start':(35, 14), 'end':(35, 24), 'text':'ChoKalpha1 overexpression produces elevated levels of both PCho and PEtn ,'}]}, {'start':(35, 25), 'end':(35, 41), 'text':'while similar ChoKbeta overexpression results only in higher levels of PEtn but normal levels of PCho ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 42), 'end':(35, 48), 'text':'we can not rule out the possibility'}, {'start':(35, 49), 'end':(35, 58), 'text':'that cell transformation requires both ChoK and EtnK activities .'}]}]}]}]}, {'start':(36, 0), 'end':(36, 33), 'text':'Consistent with the idea that links oncogenic activity to the function of ChoKalpha , but not ChoKbeta , the antiproliferative and antitumoral activity of MN58b was only associated to the activity of ChoKalpha .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(37, 0), 'end':(37, 1), 'text':'Furthermore ,'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(37, 2), 'end':(37, 5), 'text':'as previously reported ,'}, {'start':(37, 6), 'end':(37, 32), 'text':'the in vivo treatment with MN58b results in a specific decrease of PCho levels in the tumours but no significant effect on the levels of PEtn .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(38, 0), 'end':(38, 6), 'text':'Previous results from our group have demonstrated'}, {'start':(38, 7), 'end':(38, 13), 'text':'that MN58b also inhibits choline transport .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 0), 'end':(39, 15), 'text':'However this effect has a little influence in the antiproliferative and antitumoral activity of the drug'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(39, 16), 'end':(39, 27), 'text':'since HC-3 , a much more potent inhibitor of choline transporters ,'}, {'start':(39, 28), 'end':(39, 38), 'text':'is far less potent as an antiproliferative agent than MN58b .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(40, 0), 'end':(40, 25), 'text':'Furthermore , MN58b has a differential effect on either normal or tumor cells , a strong demonstration of a differential activity due to ChoK inhibition -.'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 0), 'end':(41, 8), 'text':'These results are also in keeping with the observation'}, {'start':(41, 9), 'end':(41, 26), 'text':'that ChoKalpha but not ChoKbeta is a downstream target of oncogenic molecules such as Ras and RhoA .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(42, 0), 'end':(42, 1), 'text':'Thus ,'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(42, 2), 'end':(42, 10), 'text':'while Ras activates ChoKalpha through Ral-GDS and PI3K ,'}, {'start':(42, 11), 'end':(42, 17), 'text':'and RhoA activates ChoKalpha through ROCK ,'}]}, {'start':(42, 18), 'end':(42, 29), 'text':'none of these oncogenic GTPases affect ChoKbeta activity under similar conditions .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(43, 0), 'end':(43, 4), 'text':'Again , these results indicate'}, {'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(43, 5), 'end':(43, 22), 'text':'that although both ChoK enzymes are able to phosphorylate both choline and ethanolamine under cell-free systems conditions ,'}, {'start':(43, 23), 'end':(43, 30), 'text':'they display different affinities for these substrates ,'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(43, 31), 'end':(43, 35), 'text':'and in whole-cell assays conditions'}, {'start':(43, 36), 'end':(43, 43), 'text':'they are governed by distinct regulatory pathways .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(44, 0), 'end':(44, 24), 'text':'Finally , the involvement of ChoKbeta in breast and lung cancer has been studied , ChoKalpha and beta mRNA levels were determined by Q-PCR .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(45, 0), 'end':(45, 1), 'text':'All tumour'}, {'start':(45, 2), 'end':(45, 4), 'text':'derived cell lines'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(45, 5), 'end':(45, 10), 'text':'assayed significantly overexpress ChoKalpha mRNA ,'}, {'start':(45, 11), 'end':(45, 21), 'text':'while no changes were found in the expression of ChoKbeta .'}]}]}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(46, 0), 'end':(46, 6), 'text':'Similar results have been recently reported ,'}, {'start':(46, 7), 'end':(46, 15), 'text':'using semi-quantitative PCR in breast cancer cell lines .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(47, 0), 'end':(47, 7), 'text':'In addition , it has been recently described'}, {'start':(47, 8), 'end':(47, 22), 'text':'that elevated mRNA levels of ChoKalpha is a poor prognostic factor in lung cancer .'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(48, 0), 'end':(48, 2), 'text':'These results suggest'}, {'start':(48, 3), 'end':(48, 16), 'text':'that ChoKalpha but not ChoKbeta is playing a crucial role in human carcinogenesis .'}]}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(49, 0), 'end':(49, 1), 'text':'The results'}, {'start':(49, 2), 'end':(49, 4), 'text':'shown here suggest'}]}, {'start':(49, 5), 'end':(49, 18), 'text':'that ChoKbeta and its produced metabolites are not implicated in human cell transformation .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(50, 0), 'end':(50, 4), 'text':'Therefore , all the efforts'}, {'start':(50, 5), 'end':(50, 30), 'text':'aimed at dilucidating the involvement of ChoK activity in the diagnosis , prognosis and treatment of cancer have to be focused in the ChoKalpha isoform .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(51, 0), 'end':(51, 23), 'text':'In keeping with this , recently the use of specific monoclonal anti-ChoKalpha antibodies has been proposed as a diagnostic tool in human cancer .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(52, 0), 'end':(52, 20), 'text':'Furthermore , the newly designed antitumoral agents are expected to be more specific and hence less toxic than the actual drugs'}, {'start':(52, 21), 'end':(52, 25), 'text':'used in conventional chemotherapy .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 0), 'end':(53, 5), 'text':'Due to the high structural homology'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 6), 'end':(53, 18), 'text':'displayed by both choline kinase proteins , the search for new anticancer agents'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 19), 'end':(53, 22), 'text':'based on their ability'}, {'start':(53, 23), 'end':(53, 28), 'text':'to interfere with ChoK activity ,'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(53, 29), 'end':(53, 33), 'text':'must exhibit stronger antiproliferative activity'}, {'start':(53, 34), 'end':(53, 42), 'text':'based on their specificity towards the ChoKalpha isoform .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 0), 'end':(54, 15), 'text':'The lack of specific inhibition of ChoKbeta by these newly designed compounds represents a new feature'}, {'start':(54, 16), 'end':(54, 31), 'text':'to take into account for the chemical improvement of ChoKalpha inhibitors with potential antitumoral activity .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(55, 0), 'end':(55, 4), 'text':'Furthermore , non specific drugs'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(55, 5), 'end':(55, 12), 'text':'affecting ChoKbeta may result in a muscular disease'}, {'start':(55, 13), 'end':(55, 25), 'text':'produced by the lack of cell membrane lipid reparation in muscle tissue .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(56, 0), 'end':(56, 11), 'text':'In addition , it has been recently demonstrated using a genetic approach'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(56, 12), 'end':(56, 37), 'text':'that the specific inhibition of ChoKalpha by shRNA displays antiproliferative and antitumoral activity The high specificity of this technology provides definitive evidence of an antitumoral strategy'}, {'start':(56, 38), 'end':(56, 42), 'text':'based on ChoKalpha inhibition ,'}]}, {'start':(56, 43), 'end':(56, 50), 'text':'supporting previous results with the pharmacological inhibitors .'}]}]}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'textual-organization', 'direction':'None', 'children':[{'start':(57, 0), 'end':(57, 0), 'text':'-'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(58, 0), 'end':(58, 1), 'text':'Thus ,'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(58, 2), 'end':(58, 8), 'text':'despite the high homology and similar activity'}, {'start':(58, 9), 'end':(58, 13), 'text':'displayed under cell-free conditions ,'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(58, 14), 'end':(58, 22), 'text':'ChoKalpha1 and ChoKbeta isoforms show a different substrate ability'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(58, 23), 'end':(58, 31), 'text':'and behave very differently under in vivo conditions ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(58, 32), 'end':(58, 32), 'text':'suggesting'}, {'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(58, 33), 'end':(58, 37), 'text':'that in human cells ,'}, {'start':(58, 38), 'end':(58, 56), 'text':'ChoKbeta behaves as an EtnK and its overexpression is not able to induce higher intracellular levels of PCho .'}]}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(59, 0), 'end':(59, 10), 'text':'As a consequence , ChoKbeta has no effect on cell proliferation'}, {'start':(59, 11), 'end':(59, 18), 'text':'and does not contribute to oncogenic transformation .'}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(60, 0), 'end':(60, 6), 'text':'Finally , ChoKalpha but not ChoKbeta ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(60, 7), 'end':(60, 19), 'text':'should be used as the molecular target for the design of anticancer drugs'}, {'start':(60, 20), 'end':(60, 27), 'text':'aiming at interfering with choline kinase acitivity .'}]}]}]}]}
173	233	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(0, 0), 'end':(0, 2), 'text':'Materials and Methods'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 1), 'text':'Ethics statement'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 10), 'text':'All animals were handled in strict accordance with good animal practice'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 11), 'end':(2, 19), 'text':'as defined by the Guidelines of the Spanish Government'}, {'start':(2, 20), 'end':(2, 38), 'text':'( RD 223 and 1988 , March 14 th and RD 1201 and 2005 October 10 th ) .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 17), 'text':'The animal work has been conducted under the permission and supervision of the Consejo Superior de Investigaciones Cientificas'}, {'start':(3, 18), 'end':(3, 22), 'text':'( CSIC ) Ethic Committee'}]}, {'start':(3, 23), 'end':(3, 33), 'text':'as approved in the context of the appropriate Research Project .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 3), 'text':'Cell cultures and transfections'}, {'start':(5, 0), 'end':(5, 25), 'text':'Cells were maintained under standard culture conditions of humidity ( 95 % ) , temperature ( 37degreesC ) and CO 2 ( 5 % ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 24), 'text':'Human Embryonic Kidney ( HEK293T ) , human breast adenocarcinoma ( SK-Br-3 ) and Canine Kidney Madin-Darby ( MDCK ) cells were maintained in DMEM'}, {'start':(6, 25), 'end':(6, 47), 'text':'supplemented with 10 % FBS , human non small cell lung cancer cells H1299 were maintained in RPMI with 10 % FBS .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 6), 'text':'HEK293T transfections were performed using calcium phosphate'}, {'start':(7, 7), 'end':(7, 10), 'text':'as previously described .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 10), 'text':'MDCK , SK-Br-3 and H1299 cells were transfected using lipofectamine reagent'}, {'start':(8, 11), 'end':(8, 15), 'text':'( Invitrogen , CA )'}]}, {'start':(8, 16), 'end':(8, 19), 'text':'following manufacturers recommendations .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 2), 'text':'Eukaryotic expression vectors'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 3), 'end':(9, 11), 'text':'encoding for human ChoKalpha1 and beta1 isoforms were pCDNA3b'}, {'start':(9, 12), 'end':(9, 16), 'text':'( Invitrogen , CA )'}]}]}, {'start':(9, 17), 'end':(9, 18), 'text':'and pLPneo'}]}, {'start':(9, 19), 'end':(9, 34), 'text':'( BD Biosciences Clontech , CA ) respectively , both empty vectors were used as controls'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 35), 'end':(9, 42), 'text':'but only pCDNA3b is usually represented ( data'}, {'start':(9, 43), 'end':(9, 46), 'text':'not shown ) .'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 0), 'end':(10, 5), 'text':'Constitutively activated expression pCDNA3b derivative vectors'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 6), 'end':(10, 8), 'text':'encoding for RhoA'}, {'start':(10, 9), 'end':(10, 12), 'text':'( QL ) ,'}]}]}, {'start':(10, 13), 'end':(10, 26), 'text':'Rac1 ( QL ) and Cdc42 ( QL ) have been previously described .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(11, 0), 'end':(11, 1), 'text':'Expression vector'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 2), 'end':(11, 9), 'text':'encoding to the constitutive active form of H-Ras'}, {'start':(11, 10), 'end':(11, 17), 'text':'( V12 ) have been previously described .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 0), 'end':(12, 5), 'text':'Choline kinase in vitro activity assays'}, {'start':(13, 0), 'end':(13, 11), 'text':'Eukaryotic cell extracts activity assays were carried out as previously described .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 11), 'text':'Cell extracts were incubated for 30 min at 37degreesC in a buffer'}, {'start':(14, 12), 'end':(14, 75), 'text':'containing 100 mM Tris pH 8 , 10 mM MgCl 2 and 10 mM ATP and 200 microM ( 55 mCi and nmol , 2 microCi and ml ) of [ methyl- 14 C ] choline chloride ( Amersham Biosciences , UK ) for ChoK assay or 2 - [ 14 C ] - ethan-1-ol-2-amine hydrochloride for EtnK assay ( Amersham Biosciences ) .'}]}, {'start':(15, 0), 'end':(15, 16), 'text':'For Michaelis-Menten kinetics assay , extracts of E. coli expressing human ChoKalpha1 or ChoKbeta1 were used .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(16, 0), 'end':(16, 16), 'text':'A time course reaction was performed for each substrate , the reaction was stopped each 2 minutes'}, {'start':(16, 17), 'end':(16, 27), 'text':'and a logarithmic scale was represented to obtain the Km .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 10), 'text':'Specific ChoK inhibitor MN58b was kindly provided by TCD Pharma SL'}, {'start':(17, 11), 'end':(17, 16), 'text':'( Madrid , Spain ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 8), 'text':'Analysis of phosphocholine and phosphoethanolamine production in whole cells'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(19, 0), 'end':(19, 7), 'text':'HEK293T , SK-Br-3 and H1299 cells were transfected'}, {'start':(19, 8), 'end':(19, 11), 'text':'as described above .'}]}]}]}, {'label':'background', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(20, 0), 'end':(20, 7), 'text':'After transfection , cells were labelled to equilibrium'}, {'start':(20, 8), 'end':(20, 43), 'text':'adding 1 microCi and ml [ methyl- 14 C ] choline chloride or 1 microCi and ml 2 - [ 14 C ] - ethan-1-ol-2-amine hydrochloride to the culture media for 24 h. Samples were resolved'}]}, {'start':(20, 44), 'end':(20, 45), 'text':'and quantified'}]}, {'start':(20, 46), 'end':(20, 49), 'text':'as previously described .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(21, 0), 'end':(21, 6), 'text':'Briefly , cells were rinsed with PBS'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 7), 'end':(21, 14), 'text':'and fixed with 16 % ice-cold trichloroacetic acid'}, {'start':(21, 15), 'end':(21, 18), 'text':'( TCA ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(22, 0), 'end':(22, 1), 'text':'TCA-soluble material'}, {'start':(22, 2), 'end':(22, 15), 'text':'containing choline and phosphocholine was washed three times with four volumes of diethyleter ,'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(22, 16), 'end':(22, 18), 'text':'dryed under vacuum'}, {'start':(22, 19), 'end':(22, 23), 'text':'and resuspended in water .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 20), 'text':'Samples were resolved by Thin Layer Chromatography ( TLC ) on 60A Silica gel plates ( Whatman , NJ ) ,'}, {'start':(23, 21), 'end':(23, 28), 'text':'using as liquid phase 0,9 % NaCl :'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 29), 'end':(23, 30), 'text':'methanol :'}, {'start':(23, 31), 'end':(23, 38), 'text':'ammonium hydroxide ( 50:70:5 ; v/v/v ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 8), 'text':'Radioactivity was automatically quantified by an electronic radiography system'}, {'start':(24, 9), 'end':(24, 14), 'text':'( Instantimager , CT ) .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 2), 'text':'TCA insoluble material'}, {'start':(25, 3), 'end':(25, 5), 'text':'containing hydrophobic lipids'}]}, {'start':(25, 6), 'end':(25, 12), 'text':'was used as a loading control .'}]}]}]}, {'start':(26, 0), 'end':(26, 18), 'text':'The insoluble fraction was dissolved in 0,25 N sodium hydroxide and total lipids were analyzed by scintillation counting .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 3), 'text':'Anti-choline kinase beta1 serum'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(28, 0), 'end':(28, 9), 'text':'Human ChoKbeta1 gene was cloned into a prokaryotic expression vector'}, {'start':(28, 10), 'end':(28, 18), 'text':'( pGEX-4T3 ) ( GE healthcare , UK )'}]}, {'start':(28, 19), 'end':(28, 25), 'text':'and expressed in DH5alpha Escherichia coli .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(29, 0), 'end':(29, 8), 'text':'Recombinant ChoKbeta1 was then purified by the GST system'}, {'start':(29, 9), 'end':(29, 12), 'text':'( Amersham Bioscience )'}]}, {'start':(29, 13), 'end':(29, 17), 'text':'following manufacturer \'s recommendations .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(30, 0), 'end':(30, 20), 'text':'Purified ChoKbeta1 was mixed ( 1:1 ; v and v ) with Freund \'s complete Adjuvant ( Sigma-Aldrich , MO )'}, {'start':(30, 21), 'end':(30, 34), 'text':'and then injected i.m. into white rabbits ( 80 microg and rabbit ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(31, 0), 'end':(31, 12), 'text':'Booster injections were given every 2 weeks ( 60 microg and rabbit )'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 13), 'end':(31, 15), 'text':'and the sample'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(31, 16), 'end':(31, 24), 'text':'resuspended with Freund \'s incomplete Adjuvant ( Sigma-Aldrich )'}, {'start':(31, 25), 'end':(31, 32), 'text':'( 1:1 ; v and v ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(32, 0), 'end':(32, 6), 'text':'Analysis of protein expression by Western blot'}, {'start':(33, 0), 'end':(33, 14), 'text':'Equal amounts of cell lysates were resolved by electrophoresis in a 10 % SDS-PAGE .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 0), 'end':(34, 8), 'text':'ChoKalpha expression levels were detected using monoclonal antibody AD3'}, {'start':(34, 9), 'end':(34, 12), 'text':'as previously described .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 0), 'end':(35, 6), 'text':'ChoKbeta1 was detected using the polyclonal antiserum'}, {'start':(35, 7), 'end':(35, 20), 'text':'described above as primary antibody at a standard dilution of 1 and 5000 .'}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(36, 0), 'end':(36, 2), 'text':'GTPases antibodies :'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(36, 3), 'end':(36, 25), 'text':'RhoA ( Santa Cruz Biotechnology , Germany ) , Rac1 ( Upstate , NY ) , pan-Ras ( Santa Cruz Biotechnology ) ,'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(36, 26), 'end':(36, 44), 'text':'Cdc42 ( BD Biosciences , transduction labs ) and GAPDH antibody ( Chemicon International , CA ) were used'}, {'start':(36, 45), 'end':(36, 48), 'text':'following manufacturers recommendations .'}]}]}]}]}, {'start':(37, 0), 'end':(37, 9), 'text':'HRP conjugated secondary antibodies were from Santa Cruz Biotechnology .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'temporal', 'direction':'LeftToRight', 'children':[{'start':(38, 0), 'end':(38, 14), 'text':'The specific binding was detected using the chemioluminiscence detection kit ECL ( Amersham Bioscience )'}, {'start':(38, 15), 'end':(38, 19), 'text':'following the manufacturer indications .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(39, 0), 'end':(39, 4), 'text':'Soft agar anchorage independent growth'}, {'start':(39, 5), 'end':(39, 9), 'text':'and in vivo tumorigenic assays'}]}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(40, 0), 'end':(40, 18), 'text':'Anchorage independent growth assays were performed at 5-6 weeks of incubation in HEK293T and 6-10 weeks in MDCK ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(40, 19), 'end':(40, 22), 'text':'as previously described ,'}, {'start':(40, 23), 'end':(40, 30), 'text':'plating 10 5 cells per 60-mm dish .'}]}]}]}]}]}]}]}, {'start':(41, 0), 'end':(41, 9), 'text':'Crystal violet staining was performed to enhance colony contrast .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(42, 0), 'end':(42, 8), 'text':'The number of colonies was automatically quantified by computer'}, {'start':(42, 9), 'end':(42, 16), 'text':'based image software ( Image J ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(43, 0), 'end':(43, 16), 'text':'For the in vivo assays , cells were injected ( 10 6 cells per mouse flank )'}, {'start':(43, 17), 'end':(43, 24), 'text':'s.c. in nu and nu athymic mice .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'LeftToRight', 'children':[{'start':(44, 0), 'end':(44, 6), 'text':'Mice were kept under standard laboratory conditions'}, {'start':(44, 7), 'end':(44, 14), 'text':'according to the guidelines of Spanish Government .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(45, 0), 'end':(45, 1), 'text':'Quantitative PCR'}, {'start':(46, 0), 'end':(46, 12), 'text':'ChoKalpha1 or beta1 mRNA levels were quantified by real-time reverse transcriptase PCR .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 0), 'end':(47, 7), 'text':'The RNA was extracted from the cell lines'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 8), 'end':(47, 9), 'text':'using QIAshredder'}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 10), 'end':(47, 14), 'text':'following the RNeasy Mini kit'}, {'start':(47, 15), 'end':(47, 19), 'text':'( Qiagen , Inc. )'}]}, {'start':(47, 20), 'end':(47, 26), 'text':'according to the manufacturer \'s instructions .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(48, 0), 'end':(48, 20), 'text':'The amount of 0.9 microg of total RNA , in a final concentration of 10 ng and microl per reaction ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(48, 21), 'end':(48, 22), 'text':'was retro'}, {'start':(48, 23), 'end':(48, 37), 'text':'transcribed by High-Capacity cDNA Archive Kit ( Applied Biosystems ) to the cDNA preparation .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(49, 0), 'end':(49, 23), 'text':'The reverse transcription conditions were 25degreesC for 10 min and 37degreesC for 2 h . Then , each cDNA sample was analyzed in triplicate'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(49, 24), 'end':(49, 30), 'text':'using the ABI PRISM 7700 Sequence Detector'}, {'start':(49, 31), 'end':(49, 36), 'text':'( PE Applied Biosystems ) .'}]}]}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(50, 0), 'end':(50, 4), 'text':'Real-time PCR was carried out'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(50, 5), 'end':(50, 15), 'text':'using Taqman Universal PCR Master Mix ( Applied Biosystems ) ,'}, {'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(50, 16), 'end':(50, 17), 'text':'containing ROX'}, {'start':(50, 18), 'end':(50, 21), 'text':'to normalize emissions .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(51, 0), 'end':(51, 0), 'text':'Primers'}, {'start':(51, 1), 'end':(51, 25), 'text':'used for amplification of ChoKalpha , ChoKbeta and 18S ribosomal RNA were purchased from Applied Biosystems as Taqman Gene Expression Assays ( ChoKalpha1 ID :'}]}, {'start':(51, 26), 'end':(51, 30), 'text':'Hs00608045_m1 , ChoKbeta1 ID :'}]}, {'start':(51, 31), 'end':(51, 37), 'text':'Hs01925200_s1 and 18S ribosomal RNA ID :'}]}, {'start':(51, 38), 'end':(51, 40), 'text':'Hs99999901_s1 ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(52, 0), 'end':(52, 9), 'text':'For thermal cycling , the following conditions were applied :'}, {'start':(52, 10), 'end':(52, 27), 'text':'10 min at 95degreesC and 40 cycles of 15 sec at 95degreesC and 1 min at 60degreesC .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(53, 0), 'end':(53, 12), 'text':'The data are presented as Log 10 RQ ( Relative Quantity ) .'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 0), 'end':(54, 1), 'text':'Statistical analysis'}, {'start':(55, 0), 'end':(55, 14), 'text':'Mean comparisons of ChoK activity or in-cell PCho increase between different groups were performed .'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(56, 0), 'end':(56, 8), 'text':'Continuous variables with normal distribution were compared by T-test'}, {'start':(56, 9), 'end':(56, 26), 'text':'and non normal distribution variables were compared by means of the Kruskal Wallis and Mann-Whitney U tests .'}]}]}]}]}]}]}, {'start':(57, 0), 'end':(57, 9), 'text':'Statistical significance was defined as p < = 0.05 .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(58, 0), 'end':(58, 18), 'text':'The statistical analyses were performed using SPSS software , version 13.0 ( Inc , Chicago , Illinois ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(59, 0), 'end':(59, 1), 'text':'The method'}, {'start':(59, 2), 'end':(59, 14), 'text':'used to analyze data from real-time PCR experiments was 2 -DeltaDeltaCt method ,'}]}, {'start':(59, 15), 'end':(59, 35), 'text':'comparing the relative gene expression between normal and tumoral cell lines normalized to 18S ribosomal RNA as endogenous reference gene .'}]}]}]}]}
1	18	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Background'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 11), 'text':'The Kennedy pathway generates phosphocoline and phosphoethanolamine through its two branches .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 25), 'text':'Choline Kinase ( ChoK ) is the first enzyme of the Kennedy branch of synthesis of phosphocholine , the major component of the plasma membrane .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 21), 'text':'ChoK family of proteins is composed by ChoKalpha and ChoKbeta isoforms , the first one with two different variants of splicing .'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'temporal', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 9), 'text':'Recently ChoKalpha has been implicated in the carcinogenic process ,'}, {'start':(4, 10), 'end':(4, 20), 'text':'since it is over-expressed in a variety of human cancers .'}]}, {'start':(5, 0), 'end':(5, 14), 'text':'However , no evidence for a role of ChoKbeta in carcinogenesis has been reported .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(6, 0), 'end':(6, 3), 'text':'Methodology and Principal Findings'}, {'start':(7, 0), 'end':(7, 24), 'text':'Here we compare the in vitro and in vivo properties of ChoKalpha1 and ChoKbeta in lipid metabolism , and their potential role in carcinogenesis .'}]}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 9), 'text':'Both ChoKalpha1 and ChoKbeta showed choline and ethanolamine kinase activities'}, {'start':(8, 10), 'end':(8, 23), 'text':'when assayed in cell extracts , though with different affinity for their substrates .'}]}]}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 4), 'text':'However , they behave differentially'}, {'start':(9, 5), 'end':(9, 10), 'text':'when overexpressed in whole cells .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(10, 0), 'end':(10, 7), 'text':'Whereas ChoKbeta display an ethanolamine kinase role ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(10, 8), 'end':(10, 17), 'text':'ChoKalpha1 present a dual choline and ethanolamine kinase role ,'}, {'start':(10, 18), 'end':(10, 33), 'text':'suggesting the involvement of each ChoK isoform in distinct biochemical pathways under in vivo conditions .'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(11, 0), 'end':(11, 2), 'text':'In addition ,'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'background', 'direction':'LeftToRight', 'children':[{'start':(11, 3), 'end':(11, 8), 'text':'while overexpression of ChoKalpha1 is oncogenic'}, {'start':(11, 9), 'end':(11, 16), 'text':'when overexpressed in HEK293T or MDCK cells ,'}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(11, 17), 'end':(11, 27), 'text':'ChoKbeta overexpression is not sufficient to induce in vitro cell transformation'}, {'start':(11, 28), 'end':(11, 33), 'text':'nor in vivo tumor growth .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'start':(12, 0), 'end':(12, 21), 'text':'Furthermore , a significant upregulation of ChoKalpha1 mRNA levels in a panel of breast and lung cancer cell lines was found ,'}, {'start':(12, 22), 'end':(12, 31), 'text':'but no changes in ChoKbeta mRNA levels were observed .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 27), 'text':'Finally , MN58b , a previously described potent inhibitor of ChoK with in vivo antitumoral activity , shows more than 20-fold higher efficiency towards ChoKalpha1 than ChoKbeta .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 2), 'text':'Conclusion and Significance'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 16), 'text':'This study represents the first evidence of the distinct metabolic role of ChoKalpha and ChoKbeta isoforms ,'}, {'start':(15, 17), 'end':(15, 26), 'text':'suggesting different physiological roles and implications in human carcinogenesis .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 12), 'text':'These findings constitute a step forward in the design of an antitumoral strategy'}, {'start':(16, 13), 'end':(16, 17), 'text':'based on ChoK inhibition .'}]}]}]}]}]}]}
50	112	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Results'}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(1, 0), 'end':(1, 8), 'text':'Characterization of enzymatic properties of ChoKalpha1 and ChoKbeta isoforms'}, {'label':'cause', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(2, 0), 'end':(2, 24), 'text':'The activity of both choline kinase isoforms , ChoKalpha1 and ChoKbeta , has been described previously in different mammalian tissues , however their choline kinase'}, {'start':(2, 25), 'end':(2, 37), 'text':'and and or ethanolamine kinase activities are not fully characterized , , -.'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 0), 'end':(3, 23), 'text':'Thus , we first carried out a comparative analysis of the in vitro kinase activity of the two human ChoKalpha1 and ChoKbeta isoforms ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(3, 24), 'end':(3, 26), 'text':'regarding their ability'}, {'start':(3, 27), 'end':(3, 32), 'text':'to phosphorylate choline and ethanolamine .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 7), 'text':'HEK293T cells were transfected with appropriate expression vectors'}, {'start':(4, 8), 'end':(4, 19), 'text':'carrying the human CHKA or CHKB genes or an empty vector ,'}]}, {'start':(4, 20), 'end':(4, 27), 'text':'and tested for ChoK and EtnK activity .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(5, 0), 'end':(5, 10), 'text':'Expression levels achieved were checked by Western Blot ( ) ,'}, {'start':(5, 11), 'end':(5, 20), 'text':'and the relative enzymatic activity from cell extracts estimated .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'start':(6, 0), 'end':(6, 14), 'text':'Both ChoKalpha1 and ChoKbeta displayed choline and ethanolamine kinase activities under these experimental conditions ,'}, {'start':(6, 15), 'end':(6, 25), 'text':'but the rate of conversion was apparently different ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 12), 'text':'We further analyze ChoK and EtnK kinetic activities for ChoKalpha1 and ChoKbeta isoforms'}, {'start':(7, 13), 'end':(7, 17), 'text':'using the recombinant enzymes .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(8, 0), 'end':(8, 7), 'text':'DH5alpha Escherichia coli were transformed with the gene'}, {'start':(8, 8), 'end':(8, 27), 'text':'encoding for human ChoKalpha1 or ChoKbeta and an enzymatic in vitro assay for either ChoK or EtnK activities performed .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(9, 0), 'end':(9, 16), 'text':'Michaelis constants ( Km ) for each isoform for the different substrates were obtained ( ) .'}, {'start':(10, 0), 'end':(10, 11), 'text':'ChoKbeta showed a Km for choline 2.8 times higher than ChoKalpha1 .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 13), 'text':'By contrast , the Km of ChoKbeta for ethanolamine was lower than ChoKalpha1 .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(12, 0), 'end':(12, 2), 'text':'These results suggest'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(12, 3), 'end':(12, 20), 'text':'that in cell-free systems choline is a better substrate for ChoKalpha1 ( 2.85 fold ) than ChoKbeta ,'}, {'start':(12, 21), 'end':(12, 35), 'text':'whereas ethanolamine is a better substrate for ChoKbeta ( 5.83 fold ) than ChoKalpha1 .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 9), 'text':'ChoK isoforms are differentially regulated by Ras and Rho GTPases'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(14, 0), 'end':(14, 22), 'text':'Since Ras and RhoA GTPases are upstream regulators of ChoKalpha1 , , some of the most studied proteins of the small GTPase family'}, {'start':(14, 23), 'end':(14, 42), 'text':'including H-Ras , and the Rho family members RhoA and Cdc42 were tested as potential upstream modulators of ChoKbeta .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 16), 'text':'To that end , an in vitro ChoK and EtnK activity assay was performed in HEK293T cells'}, {'start':(15, 17), 'end':(15, 33), 'text':'transfected with the constitutive active mutants of each GTPase ( ) and either ChoKalpha1 and ChoKbeta .'}]}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(16, 0), 'end':(16, 3), 'text':'As shown in ,'}, {'start':(16, 4), 'end':(16, 21), 'text':'none of the GTPases tested were able to significantly increase choline or ethanolamine kinase activity of ChoKbeta .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(17, 0), 'end':(17, 31), 'text':'By contrast , under similar conditions , Ras and RhoA were able to induce a statistically significant change in the activation of both ChoK and EtnK activities of ChoKalpha1 ( ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(18, 0), 'end':(18, 9), 'text':'Differential role between ChoK isoforms in cell transformation and tumorigenesis'}, {'label':'joint', 'direction':'None', 'children':[{'start':(19, 0), 'end':(19, 14), 'text':'The implication of ChoKalpha1 in cell transformation and human carcinogenesis has been extensively studied ,'}, {'start':(19, 15), 'end':(19, 25), 'text':'and it has been shown to display oncogenic activity , .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(20, 0), 'end':(20, 7), 'text':'Due to its extensive homology , we investigated'}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(20, 8), 'end':(20, 13), 'text':'if ChoKbeta could induce cellular transformation'}, {'start':(20, 14), 'end':(20, 20), 'text':'when overexpressed in non tumorigenic cells .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 21), 'text':'First , the ability of ChoKbeta transfected cells to promote anchorage independent cell growth was determined using the cell line HEK293T .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(22, 0), 'end':(22, 3), 'text':'As previously reported ,'}, {'start':(22, 4), 'end':(22, 16), 'text':'ChoKalpha1 induced a significant increase in the number of soft agar colonies .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 25), 'text':'By contrast , under similar conditions , ChoKbeta overexpression had no significant effect on the number nor the size of the colonies when compared to those'}, {'start':(23, 26), 'end':(23, 31), 'text':'generated by control , empty vector'}]}, {'start':(23, 32), 'end':(23, 37), 'text':'transfected HEK293T cells ( ) .'}]}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 3), 'text':'These results were confirmed'}, {'start':(24, 4), 'end':(24, 17), 'text':'using another non tumorigenic cell line from a different species such as MDCK ,'}]}, {'label':'contrast', 'direction':'LeftToRight', 'children':[{'start':(24, 18), 'end':(24, 20), 'text':'obtaining similar results'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 21), 'end':(24, 31), 'text':'despite of the lower level of overexpression of both ChoK isoforms'}, {'start':(24, 32), 'end':(24, 37), 'text':'compared to the HEK293T cells .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 18), 'text':'The differential level of expression obtained was due to the rather different efficiency in transfection for each cell lines'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 19), 'end':(25, 20), 'text':'( data'}, {'start':(25, 21), 'end':(25, 24), 'text':'not shown ) .'}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(26, 0), 'end':(26, 3), 'text':'The ability of ChoKbeta'}, {'start':(26, 4), 'end':(26, 7), 'text':'to induce tumour growth'}]}, {'start':(26, 8), 'end':(26, 11), 'text':'was also investigated .'}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 3), 'text':'Both ChoKalpha1- and ChoKbeta'}, {'start':(27, 4), 'end':(27, 15), 'text':'transfected HEK293T or MDCK cells were subcutaneously inoculated into athymic mice .'}]}, {'start':(28, 0), 'end':(28, 23), 'text':'As shown in , the overexpression of ChoKalpha1 was sufficient to induce tumour growth in immunosuppressed mice in the both cell systems analyzed .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(29, 0), 'end':(29, 3), 'text':'By contrast , cells'}, {'start':(29, 4), 'end':(29, 5), 'text':'overexpressing ChoKbeta'}]}, {'start':(29, 6), 'end':(29, 16), 'text':'were not able to induce tumor growth under similar conditions .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(30, 0), 'end':(30, 28), 'text':'As indicated above , comparison in tumor growth rates between both cell lines is related to the diverse efficiency of transfection , much higher in HEK293T ( aproxm .'}, {'start':(31, 0), 'end':(31, 7), 'text':'80-90 % ) than MDCK ( aproxm .'}]}, {'start':(32, 0), 'end':(32, 3), 'text':'15-20 % ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 0), 'end':(33, 6), 'text':'These results are in keeping with those'}, {'start':(33, 7), 'end':(33, 12), 'text':'obtained in the soft-agar experiments ,'}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(33, 13), 'end':(33, 15), 'text':'and strongly indicate'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(33, 16), 'end':(33, 28), 'text':'that overexpression of ChoKbeta is not sufficient to induce tumor growth under conditions'}, {'start':(33, 29), 'end':(33, 32), 'text':'where ChoKalpha1 does .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(34, 0), 'end':(34, 7), 'text':'ChoKbeta isoform shows preferential EtnK activity in vivo'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(35, 0), 'end':(35, 2), 'text':'We next investigated'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(35, 3), 'end':(35, 19), 'text':'if there was any difference in the enzymatic activity of both ChoK isoforms under in vivo conditions'}, {'start':(35, 20), 'end':(35, 27), 'text':'that could explain their differential biological activity .'}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(36, 0), 'end':(36, 20), 'text':'Thus , the activity of ChoKalpha1 and ChoKbeta as ChoK and and or EtnK in a whole-cell system was tested .'}, {'label':'background', 'direction':'RightToLeft', 'children':[{'start':(37, 0), 'end':(37, 7), 'text':'Intracellular lipids of human HEK293T overexpressing ChoKalpha1 ,'}, {'start':(37, 8), 'end':(37, 20), 'text':'ChoKbeta or transfected with an empty vector , were extracted an analyzed .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'start':(38, 0), 'end':(38, 5), 'text':'Both , the insoluble lipid fraction'}, {'label':'manner-means', 'direction':'LeftToRight', 'children':[{'start':(38, 6), 'end':(38, 15), 'text':'containing the hydrophobic lipids and total protein content were used'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(38, 16), 'end':(38, 18), 'text':'as loading control'}, {'start':(38, 19), 'end':(38, 22), 'text':'obtaining similar results .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(39, 0), 'end':(39, 17), 'text':'As shown in , the intracellular phosphoethanolamine levels were increased to a similar extent in ChoKalpha1- or ChoKbeta'}, {'start':(39, 18), 'end':(39, 20), 'text':'transfected cells .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'start':(40, 0), 'end':(40, 19), 'text':'However , the intracellular phosphocholine levels of ChoKbeta transfected cells were not significantly different to that of control cells ,'}, {'start':(40, 20), 'end':(40, 32), 'text':'while ChoKalpha1 transfected cells showed an increased intracellular PCho levels ( ) .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(41, 0), 'end':(41, 10), 'text':'Similar results were obtained using epithelial cells of different origins :'}, {'start':(41, 11), 'end':(41, 34), 'text':'human breast adenocarcinoma cells SK-Br-3 ( ) or the human Non Small Cell Lung Cancer ( NSCLC ) cell line H1299 ( ) .'}]}, {'start':(42, 0), 'end':(42, 20), 'text':'In addition , in all cell lines analyzed , protein expression was also determined by Western Blot analysis ( ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(43, 0), 'end':(43, 9), 'text':'Thus , the differential enzymatic activity of ChoKalpha1 and ChoKbeta'}, {'start':(43, 10), 'end':(43, 18), 'text':'found in HEK293T is not cell line specific .'}]}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(44, 0), 'end':(44, 2), 'text':'These results indicate'}, {'start':(44, 3), 'end':(44, 22), 'text':'that ChoKalpha1 but not ChoKbeta , is able to induce increased intracellular levels of PCho under in vivo conditions .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(45, 0), 'end':(45, 13), 'text':'However , under the same conditions both enzymes are able to generate phophorylethanolamine .'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(46, 0), 'end':(46, 1), 'text':'Thus ,'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(46, 2), 'end':(46, 15), 'text':'even though ChoKbeta displays both ChoK and EtnK activity under in vitro conditions ,'}, {'start':(46, 16), 'end':(46, 23), 'text':'it shows preferential EtnK activity in vivo .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 0), 'end':(47, 9), 'text':'Increased levels of ChoKalpha mRNA but not ChoKbeta in tumor'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(47, 10), 'end':(47, 12), 'text':'derived cell lines'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(48, 0), 'end':(48, 13), 'text':'In order to further investigate the relevance of each ChoK isoenzyme in tumorogenesis ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(48, 14), 'end':(48, 29), 'text':'we determined the levels of both ChoKalpha and ChoKbeta mRNA in a panel of human tumour'}, {'start':(48, 30), 'end':(48, 37), 'text':'derived cell lines by quantitative PCR technology .'}]}]}, {'start':(49, 0), 'end':(49, 55), 'text':'A panel of breast and lung cancer cell lines were compared with the primary , senescent , non tumoral cell line HMEC ( Human Mammary Epithelial Cells ) or the immortalized , non tumorogenic MCF10A cells as control breast cell lines , and primary Bronchial Epithelial Cells ( BEC ) as control lung cell line .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(50, 0), 'end':(50, 3), 'text':'All tumoral cell lines'}, {'start':(50, 4), 'end':(50, 5), 'text':'tested significantly'}]}, {'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(50, 6), 'end':(50, 8), 'text':'overexpress ChoKalpha mRNA'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(50, 9), 'end':(50, 15), 'text':'compared with the normal cell lines ,'}, {'start':(50, 16), 'end':(50, 27), 'text':'whereas no changes were found for ChoKbeta mRNA levels ( ) .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(51, 0), 'end':(51, 2), 'text':'These results indicate'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(51, 3), 'end':(51, 15), 'text':'that ChoKbeta is not specifically upregulated in breast or lung cancer cells ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(51, 16), 'end':(51, 16), 'text':'suggesting'}, {'start':(51, 17), 'end':(51, 30), 'text':'that high levels of ChoKbeta are not required for the promotion of cancer .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(52, 0), 'end':(52, 7), 'text':'MN58b is a specific inhibitor of ChoKalpha isoform'}, {'start':(53, 0), 'end':(53, 26), 'text':'The implication of ChoKalpha in human carcinogenesis has been used for the design of specific inhibitors of this enzyme as a novel anticancer strategy , , .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 0), 'end':(54, 4), 'text':'MN58b is the leading compound'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(54, 5), 'end':(54, 9), 'text':'to support this novel strategy'}, {'start':(54, 10), 'end':(54, 34), 'text':'since it has shown a potent antitumoral activity under in vivo conditions versus human colon , lung , breast and bladder tumor models , .'}]}]}]}]}]}]}]}]}]}]}]}]}, {'start':(55, 0), 'end':(55, 16), 'text':'The primary structure of mammalian ChoKbeta displays an overall 60 % homology with that of ChoKalpha1 .'}]}, {'label':'evaluation', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(56, 0), 'end':(56, 13), 'text':'The higher degree of homology lies within the choline and ethanolamine kinase domain .'}, {'start':(57, 0), 'end':(57, 19), 'text':'This homology could make it susceptible to a similar inhibition for both ChoKalpha1 and ChoKbeta with the same inhibitors .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'enablement', 'direction':'LeftToRight', 'children':[{'start':(58, 0), 'end':(58, 13), 'text':'Thus , we have investigated the specificity of MN58b towards these two ChoK isoenzymes'}, {'label':'condition', 'direction':'LeftToRight', 'children':[{'start':(58, 14), 'end':(58, 17), 'text':'in order to verify'}, {'start':(58, 18), 'end':(58, 32), 'text':'if its antitumoral effect is specifically related to the inhibition of the alpha isoform ,'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(58, 33), 'end':(58, 36), 'text':'that is the one'}, {'label':'joint', 'direction':'None', 'children':[{'start':(58, 37), 'end':(58, 41), 'text':'implicated in tumor progression ,'}, {'start':(58, 42), 'end':(58, 49), 'text':'or the drug similarly affects both isoforms .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'background', 'direction':'RightToLeft', 'children':[{'start':(59, 0), 'end':(59, 8), 'text':'Using the human ChoKalpha1 and ChoKbeta recombinant proteins ,'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(59, 9), 'end':(59, 17), 'text':'we performed an in vitro ChoK activity inhibition assay'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(59, 18), 'end':(59, 18), 'text':'using'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(59, 19), 'end':(59, 22), 'text':'increasing MN58b concentrations ,'}, {'start':(59, 23), 'end':(59, 30), 'text':'determining the IC 50 for each enzyme .'}]}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(60, 0), 'end':(60, 2), 'text':'As expected ,'}, {'label':'contrast', 'direction':'RightToLeft', 'children':[{'start':(60, 3), 'end':(60, 11), 'text':'despite the high similarity displayed between ChoK isoforms ,'}, {'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(60, 12), 'end':(60, 26), 'text':'MN58b showed a much higher specificity against ChoKalpha1 ( IC 50 = 5 microM )'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(60, 27), 'end':(60, 29), 'text':'than against ChoKbeta'}, {'start':(60, 30), 'end':(60, 37), 'text':'( IC 50 = 107.5 microM ) .'}]}]}]}]}]}]}]}, {'start':(61, 0), 'end':(61, 13), 'text':'Thus , MN58b is 21.5 times more potent against ChoKalpha1 than ChoKbeta isoform .'}]}]}
18	50	{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(0, 0), 'end':(0, 0), 'text':'Introduction'}, {'start':(1, 0), 'end':(1, 19), 'text':'Human choline kinase alpha ( ChoKalpha ) and beta ( ChoKbeta ) are members of the choline kinase family .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(2, 0), 'end':(2, 14), 'text':'In mammals this family is encoded by two separate genes , CHKA and CHKB ,'}, {'start':(2, 15), 'end':(2, 32), 'text':'resulting in three different proteins with a choline and ethanolamine kinase ( ChoK and EtnK ) domain :'}]}, {'start':(2, 33), 'end':(2, 47), 'text':'ChoKalpha1 ( NP_001268 ) , ChoKalpha2 ( NP_997634 ) and ChoKbeta1 ( NP_005189 ) .'}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'contrast', 'direction':'None', 'children':[{'start':(3, 0), 'end':(3, 13), 'text':'ChoKalpha1 differs from ChoKalpha2 in only an extra stretch of 18 amino acids ,'}, {'start':(3, 14), 'end':(3, 25), 'text':'while ChoKbeta differs from ChoKalpha1 and ChoKalpha2 in approximately 40 % .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 0), 'end':(4, 10), 'text':'The presence of the ChoK and EtnK domain confers the capacity'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(4, 11), 'end':(4, 16), 'text':'to catalyze the phosphorylation of choline'}, {'start':(4, 17), 'end':(4, 25), 'text':'( Cho ) to phosphocholine ( PCho ) .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(5, 0), 'end':(5, 10), 'text':'This constitutes the first step in the biosynthesis pathway of phosphatidylcholine'}, {'start':(5, 11), 'end':(5, 14), 'text':'( PC ) .'}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'joint', 'direction':'None', 'children':[{'start':(6, 0), 'end':(6, 7), 'text':'PC is the major phospholipid in eukaryotic membranes'}, {'start':(6, 8), 'end':(6, 21), 'text':'and plays a critical role in membrane structure and also in cell signalling .'}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 0), 'end':(7, 10), 'text':'ChoK enzymes could be implicated also in the synthesis of phosphatidylethanolamine'}, {'start':(7, 11), 'end':(7, 14), 'text':'( PE ) ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(7, 15), 'end':(7, 18), 'text':'using as substrate ethanolamine'}, {'start':(7, 19), 'end':(7, 21), 'text':'to render phosphoethanolamine'}]}, {'start':(7, 22), 'end':(7, 26), 'text':'( PEtn ) , -.'}]}]}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(8, 0), 'end':(8, 2), 'text':'Previous studies suggest'}, {'label':'joint', 'direction':'None', 'children':[{'start':(8, 3), 'end':(8, 10), 'text':'that ChoK acts as a dimeric protein ,'}, {'start':(8, 11), 'end':(8, 29), 'text':'and the proportion of the different homo- or hetero- dimer population has been proposed to be tissue specific .'}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(9, 0), 'end':(9, 22), 'text':'Furthermore , the combination between choline kinase isoforms results in a different level of ChoK activity in vitro under cell-free systems conditions .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(10, 0), 'end':(10, 23), 'text':'Thus , the alpha and alpha homodimer is the most active choline kinase form , the beta and beta homodimer the less active ,'}, {'start':(10, 24), 'end':(10, 34), 'text':'and the alpha and beta heterodimer has an intermediate phenotype .'}]}]}]}]}, {'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 0), 'end':(11, 3), 'text':'The specific phospholipase D'}, {'start':(11, 4), 'end':(11, 21), 'text':'driven hydrolysis of PC generates choline and signal transduction metabolites such as PA ( phosphatidic acid ) ,'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(11, 22), 'end':(11, 31), 'text':'and its derivatives LPA ( lysophosphatidic acid ) and DAG'}, {'start':(11, 32), 'end':(11, 35), 'text':'( diacylglycerol ) ,'}]}]}, {'start':(11, 36), 'end':(11, 44), 'text':'that are important in mitogenesis and cellular transformation -.'}]}, {'start':(12, 0), 'end':(12, 19), 'text':'Choline gets further converted by ChoK into PCho , an stable metabolite able to induce mitogenesis in murine fibroblasts .'}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'label':'same-unit', 'direction':'None', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(13, 0), 'end':(13, 12), 'text':'In addition , several oncogenes such as RAS or RHOA increase ChoKalpha activity'}, {'start':(13, 13), 'end':(13, 20), 'text':'resulting in higher intracellular levels of PCho -.'}]}, {'start':(14, 0), 'end':(14, 16), 'text':'Magnetic resonance spectroscopy ( MRS ) studies have revealed abnormal phospholipid metabolism in cancer cells , .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(15, 0), 'end':(15, 20), 'text':'Furthermore , high levels of PCho have been found in tumoral cells as well as in tumour samples of cancer patients'}, {'start':(15, 21), 'end':(15, 35), 'text':'compared with the normal counterparts in breast , prostate , brain and ovarian cancer -.'}]}, {'label':'contrast', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(16, 0), 'end':(16, 13), 'text':'The increase in phosphoethanolamine has been also reported in transformed cells or tumor samples'}, {'start':(16, 14), 'end':(16, 16), 'text':'using MRS ,'}]}, {'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(16, 17), 'end':(16, 25), 'text':'although it contributes to a much lesser extent ,'}, {'start':(16, 26), 'end':(16, 37), 'text':'compared with the increase of PCho , to the phosphomonoester peak .'}]}]}]}]}]}]}, {'label':'joint', 'direction':'None', 'children':[{'start':(17, 0), 'end':(17, 18), 'text':'The implication of ChoKalpha in cell growth , proliferation , initiation and progression of cancer is well documented .'}, {'label':'joint', 'direction':'None', 'children':[{'start':(18, 0), 'end':(18, 27), 'text':'ChoKalpha is overexpressed in some of the most common cancers , such as breast , lung , colorectal , prostate - and bladder ( unpublished observations ) .'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(19, 0), 'end':(19, 5), 'text':'Furthermore , it has oncogenic activity'}, {'start':(19, 6), 'end':(19, 11), 'text':'when overexpressed in human cells .'}]}, {'start':(20, 0), 'end':(20, 20), 'text':'Increased ChoKalpha mRNA levels have been recently described as an independent prognostic marker in non small cell lung cancer patients .'}]}]}]}]}, {'label':'background', 'direction':'LeftToRight', 'children':[{'start':(21, 0), 'end':(21, 14), 'text':'Also , human breast cancer cell lines show upregulation of ChoKalpha but not ChoKbeta ,'}, {'start':(21, 15), 'end':(21, 22), 'text':'when compared with normal mammary epithelial cells .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(22, 0), 'end':(22, 8), 'text':'In that sense , it has been recently reported'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(22, 9), 'end':(22, 19), 'text':'that in the prostate tumor mouse model ( TRAMP ) ,'}, {'label':'comparison', 'direction':'LeftToRight', 'children':[{'start':(22, 20), 'end':(22, 36), 'text':'using IHQ immunodetection of ChoKbeta , a low level expression of ChoKbeta was found in tumoral samples'}, {'start':(22, 37), 'end':(22, 42), 'text':'compared with wild type tissues .'}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(23, 0), 'end':(23, 18), 'text':'The implication of members of the Rho GTPase family in cancer onset and progression has been extensively described -.'}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(24, 0), 'end':(24, 0), 'text':'Evidence'}, {'start':(24, 1), 'end':(24, 18), 'text':'that ChoK is involved in malignant transformation along with Ras and RhoA has been provided , , .'}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(25, 0), 'end':(25, 17), 'text':'Moreover , the activity of ChoKalpha is modulated by known effectors of both Ras and RhoA , .'}, {'start':(26, 0), 'end':(26, 12), 'text':'Pharmacological inhibition of ChoKalpha has been proposed as a novel antitumoral strategy .'}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(27, 0), 'end':(27, 19), 'text':'A strong support to this strategy is based on the use of MN58b , a well characterized ChoKalpha inhibitor ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(27, 20), 'end':(27, 46), 'text':'which displays a potent antiproliferative effect in several tumoral cell lines in vitro , and a strong reduction of tumor growth in nude mice xenografts , -.'}, {'label':'joint', 'direction':'None', 'children':[{'start':(28, 0), 'end':(28, 12), 'text':'We have compared the biochemical and biological properties of ChoKalpha and ChoKbeta ,'}, {'label':'attribution', 'direction':'RightToLeft', 'children':[{'start':(28, 13), 'end':(28, 14), 'text':'and demonstrate'}, {'label':'same-unit', 'direction':'None', 'children':[{'start':(28, 15), 'end':(28, 19), 'text':'that besides their homology ,'}, {'start':(28, 20), 'end':(28, 34), 'text':'the latter is not able to induce cell transformation in HEK293T or MDCK cells .'}]}]}]}]}]}, {'start':(29, 0), 'end':(29, 14), 'text':'Moreover , we suggest differential behaviour between alpha and beta isoforms in phospholipids metabolism .'}]}]}]}]}]}]}, {'label':'elaboration', 'direction':'LeftToRight', 'children':[{'start':(30, 0), 'end':(30, 16), 'text':'Finally , the antitumoral properties of MN58b can be attributed to its specific inhibition of ChoKalpha .'}, {'start':(31, 0), 'end':(31, 7), 'text':'The implications of these findings are discussed .'}]}]}
